Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 53 Lymphoma 51 Melanoma 44 Breast Neoplasms 37 Lymphoma, Follicular 36 Leukemia, Myeloid, Acute 33 Leukemia, Lymphocytic, Chronic, B-Cell 30 Precursor Cell Lymphoblastic Leukemia-Lymphoma 29 Lymphoma, Non-Hodgkin 29 Neuroblastoma 28 Multiple Myeloma 28 Lymphoma, Large B-Cell, Diffuse 25 Prostatic Neoplasms 24 Lymphoma, Mantle-Cell 23 Myelodysplastic Syndromes 22 Lymphoma, Large-Cell, Immunoblastic 20 Neoplasms, Plasma Cell 19 Leukemia, Myeloid, Chronic-Phase 19 Lung Neoplasms 18 Hodgkin Disease 18 Carcinoma, Non-Small-Cell Lung 18 Burkitt Lymphoma 18 Ovarian Neoplasms 17 Lymphoma, B-Cell, Marginal Zone 17 Neoplasm Metastasis 16 Glioblastoma 16 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Congenital Abnormalities 15 Leukemia, Myeloid, Accelerated Phase 14 Colorectal Neoplasms 13

Interventions

Saline Solution 3 Carboplatin 2 Bevacizumab 2 talazoparib 1 stenoparib 1 senaparib 1 sargramostim 1 olaparib 1 niraparib 1 liposomal doxorubicin 1 Tranexamic Acid 1 Ropivacaine 1 Paclitaxel 1 Observation 1 Neoadjuvant Therapy 1 Hyperthermic Intraperitoneal Chemotherapy 1 Antineoplastic Agents 1 1-dodecylpyridoxal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Ovarian Cancer × sargramostim × Clear all

NCT05794659 2023-07-20

Cornerstone4

Aston Sci. Inc.

Phase 2 Not yet recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡